264 related articles for article (PubMed ID: 37919766)
1. Targeting CD24 as a novel immunotherapy for solid cancers.
Yang Y; Zhu G; Yang L; Yang Y
Cell Commun Signal; 2023 Nov; 21(1):312. PubMed ID: 37919766
[TBL] [Abstract][Full Text] [Related]
2. Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
Li X; Tian W; Jiang Z; Song Y; Leng X; Yu J
Cancer Immunol Immunother; 2024 Jan; 73(2):31. PubMed ID: 38279998
[TBL] [Abstract][Full Text] [Related]
3. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy.
Ni YH; Zhao X; Wang W
Curr Gene Ther; 2020; 20(2):109-126. PubMed ID: 32576128
[TBL] [Abstract][Full Text] [Related]
4. The biological roles of CD24 in ovarian cancer: old story, but new tales.
Gu Y; Zhou G; Tang X; Shen F; Ding J; Hua K
Front Immunol; 2023; 14():1183285. PubMed ID: 37359556
[TBL] [Abstract][Full Text] [Related]
5. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
Shen W; Shi P; Dong Q; Zhou X; Chen C; Sui X; Tian W; Zhu X; Wang X; Jin S; Wu Y; Chen G; Qiu L; Zhai W; Gao Y
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344099
[TBL] [Abstract][Full Text] [Related]
7. The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo.
Shapira S; Kazanov D; Weisblatt S; Starr A; Arber N; Kraus S
J Biol Chem; 2011 Nov; 286(47):40548-55. PubMed ID: 21976680
[TBL] [Abstract][Full Text] [Related]
8. Checkpoint CD24 function on tumor and immunotherapy.
Huang S; Zhang X; Wei Y; Xiao Y
Front Immunol; 2024; 15():1367959. PubMed ID: 38487533
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the function of CD24: A driving force in cancer.
Altevogt P; Sammar M; Hüser L; Kristiansen G
Int J Cancer; 2021 Feb; 148(3):546-559. PubMed ID: 32790899
[TBL] [Abstract][Full Text] [Related]
10. Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.
Moon SY; Han M; Ryu G; Shin SA; Lee JH; Lee CS
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894750
[TBL] [Abstract][Full Text] [Related]
11. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
Zhu J; Nie S; Wu J; Lubman DM
J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
[TBL] [Abstract][Full Text] [Related]
12. CD24 blockade as a novel strategy for cancer treatment.
Wang Y; Yu H; Yu M; Liu H; Zhang B; Wang Y; Zhao S; Xia Q
Int Immunopharmacol; 2023 Aug; 121():110557. PubMed ID: 37379708
[TBL] [Abstract][Full Text] [Related]
13. The CD24 surface antigen in neural development and disease.
Gilliam DT; Menon V; Bretz NP; Pruszak J
Neurobiol Dis; 2017 Mar; 99():133-144. PubMed ID: 27993646
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy.
Eyvazi S; Kazemi B; Dastmalchi S; Bandehpour M
Curr Cancer Drug Targets; 2018; 18(4):328-336. PubMed ID: 28820056
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression.
Lin CY; Tsai CL; Chao A; Lee LY; Chen WC; Tang YH; Chao AS; Lai CH
J Mol Med (Berl); 2021 Aug; 99(8):1125-1137. PubMed ID: 33954835
[TBL] [Abstract][Full Text] [Related]
17. Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer.
Mishra AK; Ye T; Banday S; Thakare RP; Su CT; Pham NNH; Ali A; Kulshreshtha A; Chowdhury SR; Simone TM; Hu K; Zhu LJ; Eisenhaber B; Deibler SK; Simin K; Thompson PR; Kelliher MA; Eisenhaber F; Malonia SK; Green MR
Cell Rep; 2024 Apr; 43(4):114041. PubMed ID: 38573857
[TBL] [Abstract][Full Text] [Related]
18. Heparanase promotes glioma progression via enhancing CD24 expression.
Barash U; Spyrou A; Liu P; Vlodavsky E; Zhu C; Luo J; Su D; Ilan N; Forsberg-Nilsson K; Vlodavsky I; Yang X
Int J Cancer; 2019 Sep; 145(6):1596-1608. PubMed ID: 31032901
[TBL] [Abstract][Full Text] [Related]
19. DNA Aptamers for the Malignant Transformation Marker CD24.
Fafińska J; Czech A; Sitz T; Ignatova Z; Hahn U
Nucleic Acid Ther; 2018 Dec; 28(6):326-334. PubMed ID: 30407110
[TBL] [Abstract][Full Text] [Related]
20. iNOS promotes CD24
Wang R; Li Y; Tsung A; Huang H; Du Q; Yang M; Deng M; Xiong S; Wang X; Zhang L; Geller DA; Cheng B; Billiar TR
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10127-E10136. PubMed ID: 30297396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
